Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Niels M.G. Krol"'
Autor:
C.H.M. van Deurzen, R. van Marion, J. M. Martens, W. Dinjens, Niels M.G. Krol, W F J van IJcken, Rutger W W Brouwer, Shusma C. Doebar
Publikováno v:
Virchows Archiv
Virchows Archiv. An International Journal of Pathology, 474(2), 247-251. Springer-Verlag
Virchows Archiv. An International Journal of Pathology, 474(2), 247-251. Springer-Verlag
Several models have been described as potential mechanisms for the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer (IBC). The aim of our study was to increase our understanding of DCIS progression by using massive parallel se
Autor:
Wilfred F. J. van IJcken, Winand N.M. Dinjens, Harmen J.G. van de Werken, Job van Riet, John W.M. Martens, Hendrikus J. Dubbink, Maurice P.H.M. Jansen, Peggy N. Atmodimedjo, Erwin Brosens, Guido Jenster, Leendert H. J. Looijenga, Niels M.G. Krol
Publikováno v:
The Journal of Molecular Diagnostics. 20:166-176
Exploration and visualization of next-generation sequencing data are crucial for clinical diagnostics. Software allowing simultaneous visualization of multiple regions of interest coupled with dynamic heuristic filtering of genetic aberrations is, ho
Autor:
Martin J. van den Bent, Ronald van Marion, Winand N.M. Dinjens, Hendrikus J. Dubbink, Johan M. Kros, Peter Riegman, Peggy N. Atmodimedjo, Niels M.G. Krol
Publikováno v:
The Journal of Molecular Diagnostics. 18:775-786
Cancer cells are genomically unstable and accumulate tumor type–specific molecular aberrations, which may represent hallmarks for predicting prognosis and targets for therapy. Co-deletion of chromosomes 1p and 19q marks gliomas with an oligodendrog
Autor:
John W.M. Martens, Ronald van Marion, Niels M.G. Krol, Maurice P.H.M. Jansen, Marjolein J.A. Weerts, Corine M. Beaufort, Stefan Sleijfer, Jean C. A. Helmijr, Anita M. A. C. Trapman-Jansen, Winand N.M. Dinjens
Publikováno v:
Scientific Reports, 7:2136. Nature Publishing Group
Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
Scientific Reports
The use of blood-circulating cell-free DNA (cfDNA) as ‘liquid-biopsy’ is explored worldwide, with hopes for its potential in providing prognostic or predictive information in cancer treatment. In exploring cfDNA, valuable repositories are biobank
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b1cc214b476f23f8fda4135bfe14627
https://pure.eur.nl/en/publications/f71bac04-3c60-493c-a783-2e0777baaa08
https://pure.eur.nl/en/publications/f71bac04-3c60-493c-a783-2e0777baaa08
Autor:
Wilfred F. J. van IJcken, Rob B. van der Luijt, David F. Restuccia, Francien H van Nederveen, Ronald R. de Krijger, Gaston J H Franssen, Richard A Feelders, Winand N.M. Dinjens, Bert H.J. Eussen, Wouter W. de Herder, Lindsey Oudijk, Thomas G. Papathomas, Eric J. Th. Belt, Niels M.G. Krol, Rogier A. Oldenburg, Djamailys Koffy, Annelies de Klein, Esther Korpershoek
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 101(2), 453-460. Endocrine Society
Context: Familial pheochromocytoma (PCC) has been associated with germline mutations in 16 genes. Here we investigated three siblings presenting with bilateral pheochromocytomas. In addition, the index patient also exhibited renal oncocytoma and eryt
Autor:
Lucie Evenepoel, Thomas G. Papathomas, Esther Korpershoek, Winand N.M. Dinjens, Niels M.G. Krol, Alexandre Persu, Ronald R. de Krijger
Publikováno v:
Genetics in Medicine, 17(8), 610-620. Lippincott Williams & Wilkins
Genetics in Medicine, 17(8), 610. Lippincott Williams and Wilkins
Genetics in Medicine, 17(8), 610. Lippincott Williams and Wilkins
The tricarboxylic acid, or Krebs, cycle is central to the cellular metabolism of sugars, lipids, and amino acids; it fuels the mitochondrial respiratory chain for energy generation. In the past decade, mutations in the Krebs-cycle enzymes succinate d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1818da42b03be12f590b307183bfbd69
https://pure.eur.nl/en/publications/830dd9ad-9bc0-467a-9151-6d5c5c38090c
https://pure.eur.nl/en/publications/830dd9ad-9bc0-467a-9151-6d5c5c38090c
Autor:
Marian van Fessem, Ron H.N. van Schaik, Els M.J.J. Berns, Winand N.M. Dinjens, Maxime P. Look, Niels M.G. Krol, Stefan Sleijfer, Ronald van Marion, Irene Lurkin, Kim Monkhorst, Marion Meijer van Gelder, Marcel Smid, Anita Trapman, Jean C. A. Helmijr, Diana E. Ramirez-Ardila, Corine M. Beaufort, John A. Foekens, Ellen C. Zwarthoff, John W.M. Martens, Maurice P.H.M. Jansen
Publikováno v:
Cancer Research. 75:P4-02
Background: Evaluation of cell-free DNA (cfDNA) is a very attractive tool to serve as "liquid biopsy" to define and establish mutational changes in circulating tumor DNA (ctDNA) non-invasively during therapy. Aim: To identify tumor specific mutations